As the article pointed out, 23andMe's original business model of selling genetic testing kit to consumers didn't fly after FDA's mandate of banning them and the

As the article pointed out, 23andMe's original business model of selling genetic testing kit to consumers didn't fly after FDA's mandate of banning them and they only gain 10 related gene testing approval since 2015. So they pivoted. As the article pointed out again, I still think they have some very interesting ways to generating more revenues like making drugs(a far stretch) or gene related disease analysis (fertility, breast cancer, etc.)